About MEAJO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions to authors | Online submission | Subscribe | Advertise | Contact | Login 
Middle East African Journal of Ophthalmology Middle East African Journal of Ophthalmology
Users Online: 5043   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
DIABETIC RETINOPATHY UPDATE
Year : 2015  |  Volume : 22  |  Issue : 2  |  Page : 164-173

Novel pharmacotherapies in diabetic retinopathy


1 Department of Ophthalmology, Albany Medical Center, Lions Eye Institute, Albany, NY 12208, USA
2 Department of Ophthalmology, Mayo Clinic, Rochester, MN 55905, USA

Correspondence Address:
Sophie J Bakri
Department of Ophthalmology, Mayo Clinic, Rochester, MN 55905
USA
Login to access the Email id

Source of Support: Sophie J. Bakri, was supported by Research to Prevent Blindness,, Conflict of Interest: None


DOI: 10.4103/0974-9233.154389

Rights and Permissions

This is a summary of current and emerging pharmacologic therapies utilized in the treatment of diabetic retinopathy (DR). Current therapies, such as ranibizumab, bevacizumab, triamcinolone acetonide, and fluocinolone acetonide, inhibit angiogenesis and inflammation and may be used alone or in combination with laser treatment. Emerging therapies aim to reduce oxidative stress or inhibit other signal transduction pathways, including the protein kinase C cascade and aldose reductase pathway. Future therapies may target other molecules crucial to the pathogenesis of DR, including hepatocyte growth factors and matrix metalloproteinase 9. Finally, the emergence of novel mechanisms of medication delivery may also be on the horizon.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2939    
    Printed66    
    Emailed0    
    PDF Downloaded254    
    Comments [Add]    
    Cited by others 1    

Recommend this journal